Nanox Imaging Subsidiary USARAD Holdings Expands Existing Collaboration To Further Integrate AZmed’s X-ray AI Solutions Into USARAD’s Radiology Workflows Through Nanox Marketplace

• AZmed's FDA-cleared, clinically validated X-ray AI suite to be integrated into USARAD's workflows through Nanox Marketplace
   
• Expansion builds on USARAD's existing use of AZmed AI, from acute trauma to chest X-rays, to help radiologists prioritize and read studies more efficiently
   

PETACH TIKVA, Israel, Nov. 9, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (("Nanox" or the "Company", NASDAQ:NNOX), a leader in innovative medical imaging technology, today announced that its wholly owned subsidiary, USARAD Holdings, Inc. ("USARAD"), is expanding its existing collaboration with AZmed, a medical imaging AI company specializing in AI-powered X-ray analysis, to further integrate AZmed’s X-ray AI solutions into USARAD’s radiology workflows through Nanox Marketplace.

AZmed’sRayvolve AI suite covers eight FDA-cleared findings across musculoskeletal and chest X-rays. AZtrauma is FDA-cleared as computer-assisted detection and diagnosis software for fractures, dislocations and joint effusions in adult and pediatric patients aged two and older. AZchest is FDA-cleared to assist radiologists in detecting and localizing pneumothorax, pleural effusion, consolidation and increased cardiothoracic ratio on frontal chest radiographs. Separately, Rayvolve LN is FDA-cleared to assist in detecting pulmonary nodules. Early this year, the Rayvolve AI suite was evaluated in the peer-reviewed journal Radiography in the largest published multicenter study of X-ray AI to date, covering 258,373 X-rays from 100 medical centers across 26 countries and five continents.

USARAD has worked with AZmed since 2023 and already uses AZmed’s AI, starting with AZtrauma for acute musculoskeletal trauma and, in 2026, extending to AZchest for chest X-rays. Under this agreement the suite will be further integrated into USARAD’s radiology workflows, which support a large network of radiologists across the U.S., with the goal of helping them prioritize and read studies more efficiently.

AZmed’s AI will be delivered through Nanox Marketplace, which will enable automated study routing and DICOM transmission between AZmed’s AI and connected facilities on OnePacs, USARAD’s cloud PACS platform, so AI results reach radiologists without leaving the system they already read in.